Spyre Therapeutics Inc. (NASDAQ: SYRE)
$31.01
+2.2050 ( +7.66% ) 723.0K
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. A range of pharmaceutical options to address IBD exists, including anti-inflammatory drugs, immunosuppressants, and biologics.
Market Data
Open
$31.01
Previous close
$28.80
Volume
723.0K
Market cap
$1.57B
Day range
$28.81 - $31.13
52 week range
$10.42 - $47.97
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k | 8K-related | 13 | Nov 24, 2023 |
8-k | 8K-related | 15 | Nov 15, 2023 |
10-q | Quarterly Reports | 80 | Nov 09, 2023 |
8-k | 8K-related | 14 | Nov 09, 2023 |
def | Proxies and info statements | 7 | Oct 27, 2023 |
8-k | 8K-related | 51 | Oct 24, 2023 |
8-k | 8K-related | 14 | Oct 10, 2023 |
8-k | 8K-related | 12 | Oct 05, 2023 |
8-k | 8K-related | 13 | Sep 25, 2023 |
8-k | 8K-related | 70 | Sep 08, 2023 |